跳至主要内容
临床试验/JPRN-UMIN000003840
JPRN-UMIN000003840已完成4 期

Safety and efficacy of glinide for the treatment of type 2 diabetic patients - Safety and efficacy of glinide for the treatment of type 2 diabetic patients

Keio University School of Medicine Department of Medicine Division of Nephrology, Endocrinology and Metabolism0 个研究点目标入组 30 人开始时间: 2010年7月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with pretreatment with sulfonyl urea within 3 months 2) Patients who need insulin therapy for the treatment of type 2 diabetes 3) Patients with severe liver dysfunction (AST and/or ALT 100IU/l or more) 4) Patients with severe renal dysfunction (Cr 2.5mg/dl or more) or patients under hemodialysis 5) Patients with uncontrolled hypertension (SBP 180mmHg or more, and/or DBP 110mmHg or more) 6) Patients with severe heart disease 7) Patients with onset of cardiovascular disease within 3 months 8) Patients with malignancy 9) Patients with allergy for glinide 10) Patients with pregnancy 11) Patients whom the doctors do not allow to participate the study

研究者

发起方
Keio University School of Medicine Department of Medicine Division of Nephrology, Endocrinology and Metabolism

相似试验